Safety and tolerability of the <scp>COVID</scp>‐19 messenger <scp>RNA</scp> vaccine in adolescents with juvenile idiopathic arthritis treated with tumor necrosis factor inhibitors
Dimitra Dimopoulou, Νikos Spyridis, George Vartzelis, Μαρία Τσολιά, Despoina Maritsi
Abstract
Disclosure Form Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
Topics & Concepts
TolerabilityArthritisMessenger RNATumor necrosis factor alphaImmunologyRNAMedicineVirologyCancer researchBiologyGeneInternal medicineGeneticsAdverse effectAutoimmune and Inflammatory Disorders ResearchRheumatoid Arthritis Research and TherapiesKawasaki Disease and Coronary Complications